Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Orfao

Showing results (411-420 of 504) with videos related to

Pageof 51
Sort By:
Cancers|October 13, 2021
Flow Cytometry Immunophenotyping for Diagnostic Orientation and Classification of Pediatric Cancer Based on the EuroFlow Solid Tumor Orientation Tube (STOT)Cristiane de Sá Ferreira-Facio, Vitor Botafogo, Patrícia Mello Ferrão, et al.
Blood|April 13, 2016
Phenotypic, transcriptomic, and genomic features of clonal plasma cells in light-chain amyloidosisBruno Paiva, Joaquin Martinez-Lopez, Luis A Corchete, et al.
Blood|January 13, 2016
Phenotypic and genomic analysis of multiple myeloma minimal residual disease tumor cells: a new model to understand chemoresistanceBruno Paiva, Luis A Corchete, Maria-Belen Vidriales, et al.
Research Square|February 26, 2024
Cabergoline as a Novel Strategy for Post-Pregnancy Breast Cancer Prevention in Mice and HumanNatalia García-Sancha, Roberto Corchado-Cobos, Adrián Blanco-Gómez, et al.
Cytometry. Part B, Clinical Cytometry|September 23, 2023
Minimal residual disease assessment in B-cell precursor acute lymphoblastic leukemia by semi-automated identification of normal hematopoietic cells: A EuroFlow studyMartijn W C Verbeek, Beatriz Soriano Rodríguez, Lukasz Sedek, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 14, 2022
Standards of Genetic Testing in the Diagnosis and Prognostication of Systemic Mastocytosis in 2022: Recommendations of the EU-US Cooperative GroupGregor Hoermann, Karl Sotlar, Mohamad Jawhar, et al.
Blood Cancer Journal|December 1, 2023
Determining hemodilution in diagnostic bone marrow aspirated samples in plasma cell disorders by next-generation flow cytometry: Proposal for a bone marrow quality indexJón Þórir Óskarsson, Sæmundur Rögnvaldsson, Sigrun Thorsteinsdottir, et al.
Blood Cancer Journal|October 31, 2020
Comparison of next-generation sequencing (NGS) and next-generation flow (NGF) for minimal residual disease (MRD) assessment in multiple myelomaAlejandro Medina, Noemi Puig, Juan Flores-Montero, et al.
Blood Advances|November 29, 2021
Cellular and humoral immunogenicity of the mRNA-1273 SARS-CoV-2 vaccine in patients with hematologic malignanciesMoraima Jiménez, Elisa Roldán, Candela Fernández-Naval, et al.
Blood|September 17, 2009
The persistence of immunophenotypically normal residual bone marrow plasma cells at diagnosis identifies a good prognostic subgroup of symptomatic multiple myeloma patientsBruno Paiva, Maria-Belén Vidriales, Gema Mateo, et al.
Pageof 51

Showing results (411-420 of 504) with videos related to

Sort By:
Pageof 51
Cancers|October 13, 2021
Flow Cytometry Immunophenotyping for Diagnostic Orientation and Classification of Pediatric Cancer Based on the EuroFlow Solid Tumor Orientation Tube (STOT)Cristiane de Sá Ferreira-Facio, Vitor Botafogo, Patrícia Mello Ferrão, et al.
Blood|April 13, 2016
Phenotypic, transcriptomic, and genomic features of clonal plasma cells in light-chain amyloidosisBruno Paiva, Joaquin Martinez-Lopez, Luis A Corchete, et al.
Blood|January 13, 2016
Phenotypic and genomic analysis of multiple myeloma minimal residual disease tumor cells: a new model to understand chemoresistanceBruno Paiva, Luis A Corchete, Maria-Belen Vidriales, et al.
Research Square|February 26, 2024
Cabergoline as a Novel Strategy for Post-Pregnancy Breast Cancer Prevention in Mice and HumanNatalia García-Sancha, Roberto Corchado-Cobos, Adrián Blanco-Gómez, et al.
Cytometry. Part B, Clinical Cytometry|September 23, 2023
Minimal residual disease assessment in B-cell precursor acute lymphoblastic leukemia by semi-automated identification of normal hematopoietic cells: A EuroFlow studyMartijn W C Verbeek, Beatriz Soriano Rodríguez, Lukasz Sedek, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 14, 2022
Standards of Genetic Testing in the Diagnosis and Prognostication of Systemic Mastocytosis in 2022: Recommendations of the EU-US Cooperative GroupGregor Hoermann, Karl Sotlar, Mohamad Jawhar, et al.
Blood Cancer Journal|December 1, 2023
Determining hemodilution in diagnostic bone marrow aspirated samples in plasma cell disorders by next-generation flow cytometry: Proposal for a bone marrow quality indexJón Þórir Óskarsson, Sæmundur Rögnvaldsson, Sigrun Thorsteinsdottir, et al.
Blood Cancer Journal|October 31, 2020
Comparison of next-generation sequencing (NGS) and next-generation flow (NGF) for minimal residual disease (MRD) assessment in multiple myelomaAlejandro Medina, Noemi Puig, Juan Flores-Montero, et al.
Blood Advances|November 29, 2021
Cellular and humoral immunogenicity of the mRNA-1273 SARS-CoV-2 vaccine in patients with hematologic malignanciesMoraima Jiménez, Elisa Roldán, Candela Fernández-Naval, et al.
Blood|September 17, 2009
The persistence of immunophenotypically normal residual bone marrow plasma cells at diagnosis identifies a good prognostic subgroup of symptomatic multiple myeloma patientsBruno Paiva, Maria-Belén Vidriales, Gema Mateo, et al.
Pageof 51